Antibiotics are designed to kill bacteria, not parasites, and most will do nothing against a parasitic infection. But the line isn’t as clean as it sounds. A handful of antibiotics do work against certain single-celled parasites called protozoa, and some drugs straddle both categories so thoroughly that calling them “just” an antibiotic undersells what they can do. The key distinction is which type of parasite you’re dealing with: a microscopic protozoan or a larger multicellular worm.
Why Most Antibiotics Don’t Work on Parasites
Standard antibiotics target structures and processes unique to bacteria, like bacterial cell walls or bacterial ribosomes. Parasites are eukaryotes, meaning their cells are built much more like human cells than like bacterial cells. This similarity makes it harder to design drugs that harm the parasite without also harming you. A drug that punches holes in a bacterial cell wall has nothing to latch onto when it encounters a protozoan or a worm.
This is why taking leftover amoxicillin or azithromycin for a suspected parasitic infection won’t help. The drug simply has no relevant target in the organism causing your symptoms.
The Exceptions: Antibiotics That Kill Protozoa
Several drugs originally developed as antibiotics turn out to be genuinely effective against protozoan parasites. These single-celled organisms cause infections like malaria, giardiasis, toxoplasmosis, and amoebic dysentery. The antibiotics that work against them typically exploit a metabolic quirk the parasite shares with certain bacteria.
Metronidazole is the most well-known crossover. It diffuses into protozoan cells, where it gets chemically activated and generates toxic compounds that break apart the parasite’s DNA, destroying the double helix structure and killing the cell. It’s the first-line treatment for giardiasis in the United States, where a standard 5-to-7-day course clears the infection in 90% or more of cases. It also treats amoebic dysentery and trichomoniasis.
Doxycycline, a common tetracycline antibiotic prescribed for acne and respiratory infections, is also a proven malaria drug. It blocks a key organelle inside the malaria parasite called the apicoplast, which the parasite needs to reproduce. In clinical trials, doxycycline prevented 92% to 99% of malaria infections depending on the study, and when combined with other antimalarials for treatment, cure rates reached 96% to 100%.
Trimethoprim-sulfamethoxazole (commonly sold as Bactrim) is the treatment of choice for Cyclospora infections, the parasite responsible for periodic foodborne outbreaks linked to fresh produce. The CDC notes that no highly effective alternative has been identified for people allergic to this drug. The same antibiotic combination also treats toxoplasmosis.
Paromomycin, an aminoglycoside antibiotic, works against intestinal amoebas by disrupting their protein production. It’s unusual because it’s barely absorbed from the gut. Nearly 100% of the drug stays in the intestines and passes out in stool, which makes it effective at clearing parasites living in the intestinal lining while causing minimal effects elsewhere in the body. It’s also used for a completely different parasite, visceral leishmaniasis, which affects internal organs.
Clindamycin and azithromycin appear in treatment regimens for babesiosis, a tick-borne parasitic infection of red blood cells. Azithromycin targets the same apicoplast structure that doxycycline disrupts in malaria parasites.
Protozoa vs. Worms: A Critical Difference
The antibiotics described above work against protozoa, which are single-celled organisms. They are largely useless against helminths, the parasitic worms that include tapeworms, roundworms, hookworms, and flukes. Helminths are complex multicellular animals with nervous systems, muscles, and reproductive organs. Their biology is so close to ours that developing drugs to kill them without significant side effects is one of the harder problems in medicine.
Worm infections require dedicated antiparasitic drugs with entirely different mechanisms. Albendazole and mebendazole, for instance, prevent worms from building their internal cellular scaffolding, which starves and kills them. Ivermectin paralyzes worms by blocking nerve signals unique to invertebrates. None of these are antibiotics in the traditional sense, and no traditional antibiotic can replicate what they do.
One notable exception is nitazoxanide, a broad-spectrum drug that works against both protozoa and some helminths. It’s the only FDA-approved treatment for Cryptosporidium infections and is also effective against Giardia, Cyclospora, tapeworms, roundworms, and liver flukes. It kills protozoa by disabling an enzyme essential to their energy metabolism. Its effectiveness against worms includes 80% to 100% eradication of pinworm infections, 96% for hookworm, and 94% for threadworm.
Why Getting the Right Diagnosis Matters
Because different parasites require completely different drugs, the specific organism causing your infection determines the treatment. Taking metronidazole for a tapeworm won’t work. Taking albendazole for giardiasis won’t either. Your doctor will typically need a stool sample, blood test, or imaging to identify the parasite before prescribing anything.
This is also why self-treating with antibiotics is particularly unhelpful for suspected parasitic infections. Even the antibiotics that do kill parasites only work against specific species. Using the wrong one wastes time, may cause side effects, and can contribute to drug resistance.
Growing Resistance Is Shrinking Options
The small number of antibiotics and antiparasitic drugs that work against protozoa is getting even smaller. Resistance has emerged to some of the most effective drugs ever developed for parasitic infections: chloroquine for malaria, metronidazole for anaerobic parasites like Giardia and Trichomonas, and sulfonamide-based drugs for toxoplasmosis. Because the total number of antiprotozoal drugs is limited to begin with, losing even one to resistance creates a significant gap in treatment options, especially in regions where these infections are most common.